Apolipoprotein A-I was isolated from mouse plasma by density gradient centrifugation followed by HPLC purification.
Localization
Secreted
Specificity
Typically less than 1% cross reactivity against other types of apoLipoprotein was detected by ELISA.This reacts with mouse apoLipoprotein A-I and has negligible cross-reactivity with Type A-II, B, C-I, C-II, C-III, E and J apoLipoproteins.
Isotype
IgG
Clonality
Polyclonal
Host
Goat
Gene
APOA1
Purity
Immunogen affinity purified
Innovator's Reward
Test in a species/application not listed above to receive a full credit towards a future purchase.
Anti-apoLipoprotein antibodies have been used for indirect trapping ELISA for quantitation of antigen in serum using a standard curve, for immunoprecipitation and for western blotting for highly sensitive qualitative analysis. Immunocytochemistry/Immunofluorescence was reported in scientific literature.
Publications
Read Publications using NB600-609 in the following applications:
Human reactivity reported in scientific literature (PMID:32796843). Human reactivity reported in scientific literature (PMID: 26360112).. Specific cross-reaction with Apolipoprotein A-I from other species has not been determined Non-specific cross-reaction with other human serum proteins is negligible.
Packaging, Storage & Formulations
Storage
Store at 4C short term. For extended storage, add an equal volume of glycerol, aliquot and store at -20C or below. Avoid repeated freeze-thaw cycles.
Buffer
0.125 M Sodium Borate, 0.075 M Sodium Chloride, 0.005 M EDTA, pH 8.0
Preservative
0.01% Sodium Azide
Concentration
1 mg/ml
Purity
Immunogen affinity purified
Alternate Names for Apolipoprotein A-I/ApoA1 Antibody
Alp-1
APOA1
Apo-AI
apoA-I
Apolipoprotein A1
Apolipoprotein AI
Apolipoprotein A-I
Brp-14
Ltw-1
Lvtw-1
MGC117399
Sep-1
Sep-2
Background
At least 9 distinct polymorphic forms of apolipoproteins are known. The apolipoproteins act as stabilizers of the intact lipoprotein particles. Quantitative measurements of HDL, LDL and VLDL particles in human serum are often used to estimate an individuals' relative risk of coronary heart disease. In addition, quantitative immunological measurements of certain apolipoproteins (especially A-1 and B) have been suggested to be more accurate estimators of coronary heart disease than measurements of lipoprotein particles (especially HDL and LDL). This apo-lipoprotein is derived from human plasma by density gradient ultracentrifugation and HPLC.
Limitations
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Reviews for Apolipoprotein A-I/ApoA1 Antibody (NB600-609) (0)
There are no reviews for Apolipoprotein A-I/ApoA1 Antibody (NB600-609).
By submitting a review you will receive an Amazon e-Gift Card or Novus Product Discount.
Review with no image -- $10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen
Review with an image -- $25/€18/£15/$25 CAD/¥150 Yuan/¥2500 Yen
Product General Protocols
Find general support by application which include: protocols, troubleshooting, illustrated assays, videos and webinars.
Bioinformatics Tool for Apolipoprotein A-I/ApoA1 Antibody (NB600-609)
Discover related pathways, diseases and genes to Apolipoprotein A-I/ApoA1 Antibody (NB600-609). Need help?
Read the Bioinformatics Tool Guide for instructions on using this tool.
Diseases for Apolipoprotein A-I/ApoA1 Antibody (NB600-609)
Discover more about diseases related to Apolipoprotein A-I/ApoA1 Antibody (NB600-609).
The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.
=
÷
Review this Product
Be the first to review our Apolipoprotein A-I/ApoA1 Antibody and receive a gift card or discount.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.